Js. Galati et al., THE NATURE OF COMPLICATIONS FOLLOWING LIVER-BIOPSY IN TRANSPLANT PATIENTS WITH ROUX-EN-Y CHOLEDOCHOJEJUNOSTOMY, Hepatology, 20(3), 1994, pp. 651-653
Liver biopsy is an important diagnostic tool in the management of pati
ents following orthotopic liver transplant. We evaluated complications
following percutaneous liver biopsy in a group of liver transplant pa
tients who had Roux-en-Y choledochojejunostomies fashioned as part of
their biliary reconstruction during liver transplantation. Complicatio
ns were divided into two major groups: septic complications (including
fever, symptomatic bacteremia, cholangitis, infected hematoma and hyp
otension related to sepsis) and bleeding (defined as hypotension requi
ring volume expansion greater than 500 cm(3) or blood transfusion, hem
othorax, intrahepatic or peritoneal hemorrhage and hemobilia occurring
within 1 wk of liver biopsy). One hundred ninety-two biopsies were pe
rformed in 46 patients with choledochojejunostomies, and 118 biopsies
were carried out in an age- and sex-matched control group of patients
with choledochocholedochostomy biliary anastomosis. There were no sept
ic complications in the choledochojejunostomy patients and one (0.32%)
septic complication in the choledochocholedochostomy patients (NS). E
ight bleeding complications occurred (2.6%) in eight patients (8.3%).
Five (2.6%) occurred in five (10.8%) of the choledochojejunostomy pati
ents, vs. three (2.5%) in three (6.5%) choledochocholedochostomy patie
nts (NS). None of the bleeding complications required surgical interve
ntion or was fatal. We conclude that liver biopsy in posttransplant pa
tients with Roux-en-Y choledochojejunostomies is a safe procedure and
that the incidences of complications were similar in our two groups. T
he negligible incidence of septic complications in the choledochojejun
ostomy patients does not appear to warrant the administration of proph
ylactic antibiotics, as has been previously suggested.